Abstract
Remethylation of homocysteine to methionine is dependent on an adequate supply of one or more of the B vitamins like folate, vitamin B12 and vitamin B6. Plasma total homocysteine (tHcy) is also influenced by genetic factors such as polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene. MTHFR is a flavo enzyme and a key player in folate metabolism and changes in its activity could modify the susceptibility to Acute Lymphoblastic Leukemia (ALL). In this case — control study we have examined the effect of riboflavin status as measured by erythrocyte glutathione reductase activation coefficient (EGRAC) on homocysteine levels along with vitamin B12 and folate in pediatric ALL. Folate and B12 levels were significantly lower among cases as compared to controls while EGRAC and tHcy did not differ significantly among the groups. The multivariate regression analysis revealed that in the ALL group EGRAC significantly influences tHcy levels suggesting that riboflavin availability may be a predictor of tHcy levels in patients with ALL. This finding may have implications for tHcy lowering therapy.
Key Words: Homocysteine, Riboflavin, MTHFR, Acute Lymphoblastic Leukemia
Full Text
The Full Text of this article is available as a PDF (58.0 KB).
References
- 1.McNulty H., McKinley M.C., Wilson B., Mcparlin J., Strain J.J., Weir D.G., et al. Impaired functioning of thermolabile methylenetetrahydrofolate reductase is dependent on riboflavin status: implication for riboflavin requirements. Am J Clin Nutr. 2002;76:436–441. doi: 10.1093/ajcn/76.2.436. [DOI] [PubMed] [Google Scholar]
- 2.Kumar J., Das S.K., Sharma P., Karthikeyan G., Ramakrishnan L., Sengupta S. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J Hum Genet. 2005;50:655–663. doi: 10.1007/s10038-005-0313-1. [DOI] [PubMed] [Google Scholar]
- 3.Guenther B.D., Sheppard C.A., Tran P., Rozen R., Mathews R.G., Ludwig M.L. The structure and properties of MTHFR from E.coli suggests how folate ameliorates human hyperhomocysteinemia. Nat Struct Biol. 1999;6:359–365. doi: 10.1038/7594. [DOI] [PubMed] [Google Scholar]
- 4.Frantzen F., Faaren A.L., Alfheim I., Nordha A.K. An Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem. 1998;44(22):311–316. [PubMed] [Google Scholar]
- 5.Sauberlich H.E., Judd J.H., Nichoalds G.E., Broquist H.P., Darby W.J. Application of the EGR assay in evaluating riboflavin nutritional status in a high school student population. Am J Clin Nutr. 1972;25:756–762. doi: 10.1093/ajcn/25.8.756. [DOI] [PubMed] [Google Scholar]
- 6.Chen I.W., Silberstein E.B., Maxon H.R., Volle C.P., Sohnlein B.H. Semi automated system for simultaneous assay of serum Vitamin B12 and Folic acid in serum evaluated. Clin Chem. 1982;28(10):2161–2165. [PubMed] [Google Scholar]
- 7.Stanislawska-Sachadyn A., Woodside J.V., Brown K.S., Young I.S., Murray L., McNulty H. Evidence for sex differences in the determinants of homocysteine concentrations. Mol Genet Metabol. 2008;93:355–362. doi: 10.1016/j.ymgme.2007.11.004. [DOI] [PubMed] [Google Scholar]
- 8.Hustad S., Schneede J., Ueland P.M. In: Riboflavin and Methylenetetrahydrofolate reductase in MTHFR polymorphisms and Disease. Ueland P.M., Rozen R., editors. Georgetown, Texas: Landes Bioscience; 2005. pp. 71–77. [Google Scholar]
- 9.Hustad S., Ueland P.M., Vollset S.E., Zhang Y., Monsen-Bjorke A.L., Schneede J. Riboflavin as a determinant of plasma total homocysteine: Effect modification by the methylenetetrahydrofolate reductase C677T polymorphism. Clin Chem. 2000;46:1065–1071. [PubMed] [Google Scholar]
- 10.Jacques P.F., Kalmbach R., Bagley P.J. The relationship between riboflavin and plasma total homocysteine in the Framingham offspring cohort is influenced by folate status and the C677T transition in the methylenetetrahydrofolate reductase gene. J Nutr. 2002;132:283–288. doi: 10.1093/jn/132.2.283. [DOI] [PubMed] [Google Scholar]
- 11.Skoupy S., Fodinger M., Veitl M., Perschl A., Puttinger H., Rohrer C., et al. Riboflavin is a Determinant of Total Homocysteine Plasma Concentrations in End-Stage Renal Disease Patients. J Am Soc Nephol. 2002;13:1331–1337. doi: 10.1097/01.ASN.0000013299.11876.F6. [DOI] [PubMed] [Google Scholar]